|
1
|
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
|
Am J Hum Genet
|
2007
|
3.63
|
|
2
|
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
|
Nature
|
2011
|
3.53
|
|
3
|
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
PLoS Genet
|
2013
|
2.39
|
|
4
|
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
|
J Clin Endocrinol Metab
|
2009
|
2.22
|
|
5
|
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.75
|
|
6
|
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
|
Hum Mol Genet
|
2011
|
1.51
|
|
7
|
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.
|
Clin Cancer Res
|
2011
|
1.24
|
|
8
|
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
|
Breast Cancer Res
|
2011
|
1.22
|
|
9
|
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.17
|
|
10
|
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.
|
J Med Genet
|
2011
|
1.14
|
|
11
|
Patients' characteristics and rate of Internet use to obtain cancer information.
|
J Public Health (Oxf)
|
2006
|
1.08
|
|
12
|
Letter to the editor: Pregnancy and von Hippel-Lindau disease.
|
J Neurosurg
|
2013
|
1.07
|
|
13
|
Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
|
J Clin Endocrinol Metab
|
2012
|
1.06
|
|
14
|
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.
|
Eur J Cancer
|
2006
|
0.97
|
|
15
|
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
|
Int J Cancer
|
2005
|
0.91
|
|
16
|
Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO).
|
Breast Cancer Res Treat
|
2011
|
0.90
|
|
17
|
Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families.
|
Oncogene
|
2002
|
0.89
|
|
18
|
BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
|
Genet Med
|
2012
|
0.86
|
|
19
|
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.86
|
|
20
|
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).
|
Breast Cancer Res
|
2012
|
0.85
|
|
21
|
Association of hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) and malignant melanoma in two patients.
|
Melanoma Res
|
2007
|
0.84
|
|
22
|
Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent?
|
Cancer
|
2005
|
0.80
|
|
23
|
Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours.
|
Eur J Hum Genet
|
2013
|
0.80
|
|
24
|
Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutations.
|
PLoS One
|
2012
|
0.78
|
|
25
|
A family with two cases of melanocytic tumors and fragile X syndrome.
|
Melanoma Res
|
2017
|
0.75
|